Lacie Hirayama is a patent agent in the Intellectual Property Practice Group in the firm's Silicon Valley office.
Dr. Hirayama assists attorneys in preparing and prosecuting U.S. and foreign patent applications in the chemical, pharmaceutical, medical device and nanotechnology arenas.
She is a graduate of UCSC, where her research was largely directed toward the development of novel asymmetric methodologies for the synthesis of chiral small molecules. In addition, she was a member of a team who focused on the development of an in-vivo fluorescent hydrogel-based glucose-sensing ensemble. Dr. Hirayama's areas of scientific experience include organic, organometallic and polymer chemistry.